Tshawb Nrhiav | Blue Cross MN

Nthuav pom cov txiaj ntsig tshwm sim 2471 - 2480 ntawm 3159

Tus kws kho mob

P6-20 Sleep Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020

Tus kws kho mob

P3-20 Radiology Oncology Imaging Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020

Tus kws kho mob

P2-20 Radiation Oncology Program Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020

Tus kws kho mob

P1-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates – Effective March 2, 2020

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020

Tus kws kho mob

P4-20 Lab Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020

Tus kws kho mob

P7-20 Musculoskeletal Management Program Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020

Tus kws kho mob

P5-20 Cardiology & Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020

Tus kws kho mob

QP107-19 Medical Drug Update for Rituximab Biosimilars (Truxima, Ruxience) – Commercial Products

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 11, 2019

Tus kws kho mob

QP105-19 Understanding Vision Benefits within Eligibility & Benefits Inquiry Response

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 11, 2019

Tus kws kho mob

QP103-19 Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 11, 2019